source Post navigation Overactive cells linked with type 2 diabetes – Futurity: Research News NLS Pharmaceutics and Kadimastem Announce the Submission of a Request by Kadimastem and iTolerance, Inc. for an FDA Pre-IND Meeting for an Innovative Breakthrough Type 1 Diabetes Treatment – Yahoo Finance